SCHEMBL19102194

SCHEMBL19102194

NC(=O)C1CCN(Cc2cccc(-c3cnc(N)c(C(=O)Nc4ccccc4)n3)c2)CC1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 20/20 0.73
▸ PRKDC P78527 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19102163 0.89 ATR (0.77) ATRPRKDC
SCHEMBL19102144 0.88 ATR (0.73) ATRPRKDC
SCHEMBL19102095 0.88 ATR (0.70) ATRPRKDC
SCHEMBL19102198 0.85 ATR (0.72) ATRPRKDC
SCHEMBL2483214 0.84 ATR (1.00) ATRPRKDC
SCHEMBL2484781 0.79 ATR (1.00) ATRPRKDC
SCHEMBL20283680 0.78 ATR (1.00) ATRPRKDC
SCHEMBL19102091 0.77 ATR (0.98) ATRPRKDC
SCHEMBL19102197 0.77 ATR (0.73) ATRPRKDC
SCHEMBL2485733 0.76 ATR (1.00) ATRPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701674-B2 Substituted pyrazines as ATR kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-11 — — US disclosed
Send feedback